The relationship between the SUSD3 gene and key immunomodulators, tumor mutational burden (TMB), and microsatellite instability (MSI) was also explored, further establishing SUSD3 as a promising biomarker for cancer immunotherapy. The gene discussed is SUSD3; the disease is neoplasm.